ArticleHaematologica2024

A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma.

Hayley M Sabol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.